| Nov 7 |
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
|
| Nov 4 |
US Penny Stocks: November 2024's Top Picks To Consider
|
| Nov 1 |
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
|
| Sep 17 |
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
|
| Sep 5 |
Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More
|
| Sep 4 |
Athira plunges as Alzheimer’s trial setback leads to downgrades
|
| Sep 4 |
Alzheimer’s Trial Failure Sends Athira Stock Down 75%
|
| Sep 4 |
Athira’s stock topples after Alzheimer’s drug flops in Phase II/III trial
|
| Sep 4 |
ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal
|
| Sep 4 |
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks
|
